Form D · Pharmaceuticals
MELIOR DISCOVERY, INC
Exton, PA · CIK 0001364001
Offering snapshot reported Feb 6, 2013 · SEC filing
- Reported sold
- $1.74M Offering amount: $3.84M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 22, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 6, 2013 | Initial | $1,741,599 | No comparison | 14 | SEC filing |
| Sep 24, 2009 | Initial | $825,000 | No comparison | 4 | SEC filing |
| Jul 30, 2009 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Jun 21, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-191399
Source: Form D, filed Feb 6, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert S Adelson | Director |
| John Farah | Director |
| Jeffrey Handler | Executive |
| Robert Imershein | Director |
| Donald Marvin | Director |
| Toby Moskovits | Director |
| Toby Moskowitz | Director |
| Andrew Reaume | Director, Executive |
| Michael S. Saporito | Executive |
| Michael Sapporito | Director, Executive |
| Jeffry Vaught | Director |
| Bobba Venkatadri | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
860 Springdale Drive
Exton, PA, 19341
Exton, PA, 19341